ARFGEF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.246600E-01
Normal-vs-Stage2
6.218200E-01
Normal-vs-Stage3
5.722000E-02
Normal-vs-Stage4
8.852600E-01
Stage1-vs-Stage2
6.702600E-01
Stage1-vs-Stage3
5.041200E-03
Stage1-vs-Stage4
9.758000E-01
Stage2-vs-Stage3
4.686200E-02
Stage2-vs-Stage4
7.096000E-01
Stage3-vs-Stage4
3.120200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.690600E-01
Normal-vs-AfricanAmerican
8.656800E-01
Normal-vs-Asian
4.160000E-01
Caucasian-vs-AfricanAmerican
3.876000E-01
Caucasian-vs-Asian
3.950000E-01
AfricanAmerican-vs-Asian
2.047000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.689600E-01
Normal-vs-Female
6.907600E-01
Male-vs-Female
9.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.221800E-01
Normal-vs-Age(41-60Yrs)
9.233000E-01
Normal-vs-Age(61-80Yrs)
5.051800E-01
Normal-vs-Age(81-100Yrs)
3.251800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.794400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.984200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.053600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.027960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.214100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.244600E-01
Normal-vs-Daily Drinker
5.002400E-01
Normal-vs-Weekly Drinker
3.714600E-01
Normal-vs-Occasional Drinker
8.959400E-01
Normal-vs-Social Drinker
9.591400E-01
Non Drinker-vs-Daily Drinker
8.090800E-01
Non Drinker-vs-Weekly Drinker
8.626600E-01
Non Drinker-vs-Occasional Drinker
5.497600E-02
Non Drinker-vs-Social Drinker
2.567200E-01
Daily Drinker-vs-Weekly Drinker
7.117800E-01
Daily Drinker-vs-Occasional Drinker
1.079210E-01
Daily Drinker-vs-Social Drinker
3.311000E-01
Weekly Drinker-vs-Occasional Drinker
6.094400E-02
Weekly Drinker-vs-Social Drinker
2.373200E-01
Occasional Drinker-vs-Social Drinker
9.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.133600E-01
Normal-vs-Grade 2
3.914100E-02
Normal-vs-Grade 3
5.420200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.665600E-01
Grade 1-vs-Grade 3
7.047200E-01
Grade 1-vs-Grade 4
2.133600E-01
Grade 2-vs-Grade 3
6.194200E-02
Grade 2-vs-Grade 4
3.914100E-02
Grade 3-vs-Grade 4
5.420200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.594600E-01
Normal-vs-NonDiabetic
6.610800E-01
Diabetic-vs-NonDiabetic
1.210770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.975400E-01
Normal-vs-NoPancreatitis
5.926800E-01
Pancreatitis-vs-NoPancreatitis
7.066400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.213200E-01
Normal-vs-N1
6.385400E-01
N0-vs-N1
9.892800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.351600E-01
Normal-vs-TP53-NonMutant
9.891200E-01
TP53-Mutant-vs-TP53-NonMutant
8.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
